Johnson & Johnson reports $24.06 billion revenue for quarter ended March 29, 2026, up 9.9%
Johnson & Johnson reported revenue of $24.06 billion for the quarter ended March 29, 2026, an increase of 9.9% from the same quarter a year earlier ($21.89 billion).
For the same period it posted net income of $5.24 billion, down 52.4%, or $2.14 per diluted share (4.54 a year earlier).
That is a net margin of 21.8%.
On Sanad's AAOIFI Standard 21 screen, Johnson & Johnson is currently compliant: interest-bearing debt is 6.7% of market capitalisation (limit 30%), and impure income is 1.1% of revenue (limit 5%).
Is Johnson & Johnson halal?
See the full AAOIFI screening of Johnson & Johnson
See the full AAOIFI screening of Johnson & Johnson
Source: 10-Q filed with the U.S. Securities and Exchange Commission on April 22, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.